CHEBI:82720 - empagliflozin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name empagliflozin
ChEBI ID CHEBI:82720
Definition A C-glycosyl compound consisting of a β-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Toni Morrison
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C23H27ClO7
Net Charge 0
Average Mass 450.90900
Monoisotopic Mass 450.145
InChI InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1
InChIKey OBWASQILIWPZMG-QZMOQZSNSA-N
SMILES OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(O[C@H]3CCOC3)cc2)c1
Roles Classification
Biological Role(s): sodium-glucose transport protein subtype 2 inhibitor
An inhibitor that interferes with the action of sodium-glucose transport protein subtype 2.
Application(s): hypoglycemic agent
A drug which lowers the blood glucose level.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing empagliflozin (CHEBI:82720) has role hypoglycemic agent (CHEBI:35526)
empagliflozin (CHEBI:82720) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273)
empagliflozin (CHEBI:82720) is a C-glycosyl compound (CHEBI:20857)
empagliflozin (CHEBI:82720) is a aromatic ether (CHEBI:35618)
empagliflozin (CHEBI:82720) is a monochlorobenzenes (CHEBI:83403)
empagliflozin (CHEBI:82720) is a tetrahydrofuryl ether (CHEBI:47814)
Incoming Synjardy (CHEBI:90875) has part empagliflozin (CHEBI:82720)
IUPAC Name
(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol
Synonyms Sources
(1S)-1,5-anhydro-1-C-{4-chloro-3-((4-{((3S)-oxolan-3-yl)oxy}phenyl)methyl)phenyl}-D-glucitol ChemIDplus
1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene ChemIDplus
BI 10773 ChemIDplus
BI-10773 ChemIDplus
BI10773 ChemIDplus
empagliflozin KEGG DRUG
Brand Name Source
JARDIANCE KEGG DRUG
Database Links Databases
4830 DrugCentral
D10459 KEGG DRUG
Empagliflozin Wikipedia
View more database links
Registry Numbers Types Sources
12378768 Reaxys Registry Number Reaxys
864070-44-0 CAS Registry Number KEGG DRUG
864070-44-0 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
23859488 PubMed citation Europe PMC
23859534 PubMed citation Europe PMC
23906415 PubMed citation Europe PMC
24226524 PubMed citation Europe PMC
24491572 PubMed citation Europe PMC
24716752 PubMed citation Europe PMC
24722494 PubMed citation Europe PMC
24746173 PubMed citation Europe PMC
24766495 PubMed citation Europe PMC
24795251 PubMed citation Europe PMC
24929430 PubMed citation Europe PMC
24944269 PubMed citation Europe PMC
24948511 PubMed citation Europe PMC
24958326 PubMed citation Europe PMC
24964723 PubMed citation Europe PMC
24991224 PubMed citation Europe PMC
24993361 PubMed citation Europe PMC
25061325 PubMed citation Europe PMC
25161155 PubMed citation Europe PMC
25199997 PubMed citation Europe PMC
25260362 PubMed citation Europe PMC
25271206 PubMed citation Europe PMC
25274537 PubMed citation Europe PMC
25296258 PubMed citation Europe PMC
25301180 PubMed citation Europe PMC
Last Modified
22 February 2017